NCT02983461View on ClinicalTrials.gov

Use of Sildenafil for Treatment of Urinary Incontinence

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 10, 2017

Primary Completion Date

March 1, 2020

Study Completion Date

July 31, 2027

Conditions
Urinary Incontinence
Interventions
DRUG

Sildenafil

Sildenafil, 20mg x 3 times a day for 10 weeks

DRUG

Placebo

Placebo oral tablet, 3 times a day for 10 weeks

Trial Locations (1)

77555

University of Texas Medical Branch, Galveston

All Listed Sponsors
lead

The University of Texas Medical Branch, Galveston

OTHER